210 related articles for article (PubMed ID: 20664054)
1. An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.
Pham LV; Tamayo AT; Li C; Bueso-Ramos C; Ford RJ
Blood; 2010 Nov; 116(19):3899-906. PubMed ID: 20664054
[TBL] [Abstract][Full Text] [Related]
2. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
3. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.
Pham LV; Tamayo AT; Yoshimura LC; Lin-Lee YC; Ford RJ
Blood; 2005 Dec; 106(12):3940-7. PubMed ID: 16099873
[TBL] [Abstract][Full Text] [Related]
4. IUGR increases chromatin-remodeling factor Brg1 expression and binding to GR exon 1.7 promoter in newborn male rat hippocampus.
Ke X; McKnight RA; Gracey Maniar LE; Sun Y; Callaway CW; Majnik A; Lane RH; Cohen SS
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R119-27. PubMed ID: 25972460
[TBL] [Abstract][Full Text] [Related]
5. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
6. Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling.
Cajigas I; Leib DE; Cochrane J; Luo H; Swyter KR; Chen S; Clark BS; Thompson J; Yates JR; Kingston RE; Kohtz JD
Development; 2015 Aug; 142(15):2641-52. PubMed ID: 26138476
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.
Akimzhanov A; Krenacs L; Schlegel T; Klein-Hessling S; Bagdi E; Stelkovics E; Kondo E; Chuvpilo S; Wilke P; Avots A; Gattenlöhner S; Müller-Hermelink HK; Palmetshofer A; Serfling E
Am J Pathol; 2008 Jan; 172(1):215-24. PubMed ID: 18156209
[TBL] [Abstract][Full Text] [Related]
8. NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.
Köenig A; Linhart T; Schlengemann K; Reutlinger K; Wegele J; Adler G; Singh G; Hofmann L; Kunsch S; Büch T; Schäfer E; Gress TM; Fernandez-Zapico ME; Ellenrieder V
Gastroenterology; 2010 Mar; 138(3):1189-99.e1-2. PubMed ID: 19900447
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin/NFATc1 pathway contributes to cell proliferation in hepatocellular carcinoma.
Wang S; Kang X; Cao S; Cheng H; Wang D; Geng J
Dig Dis Sci; 2012 Dec; 57(12):3184-8. PubMed ID: 22722879
[TBL] [Abstract][Full Text] [Related]
10. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
11. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
[TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.
Husain A; Begum NA; Taniguchi T; Taniguchi H; Kobayashi M; Honjo T
Nat Commun; 2016 Feb; 7():10549. PubMed ID: 26842758
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.
Buchholz M; Schatz A; Wagner M; Michl P; Linhart T; Adler G; Gress TM; Ellenrieder V
EMBO J; 2006 Aug; 25(15):3714-24. PubMed ID: 16874304
[TBL] [Abstract][Full Text] [Related]
14. Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway.
Song J; Zou D; Zhao X; Chen Y; Lv F; Wang S; Sui D; Han Q; Yang C; Wang X; Liu B; Deng M; Zhang Y
Carcinogenesis; 2021 Feb; 42(2):303-314. PubMed ID: 33124657
[TBL] [Abstract][Full Text] [Related]
15. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
[TBL] [Abstract][Full Text] [Related]
16. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
17. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
Cubedo E; Gentles AJ; Huang C; Natkunam Y; Bhatt S; Lu X; Jiang X; Romero-Camarero I; Freud A; Zhao S; Bacchi CE; Martínez-Climent JA; Sánchez-García I; Melnick A; Lossos IS
Blood; 2012 Jun; 119(23):5478-91. PubMed ID: 22517897
[TBL] [Abstract][Full Text] [Related]
18. NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2.
Wang L; Wang Z; Li J; Zhang W; Ren F; Yue W
Int J Mol Med; 2015 May; 35(5):1333-40. PubMed ID: 25738651
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
20. Global Regulatory DNA Potentiation by SMARCA4 Propagates to Selective Gene Expression Programs via Domain-Level Remodeling.
Lazar JE; Stehling-Sun S; Nandakumar V; Wang H; Chee DR; Howard NP; Acosta R; Dunn D; Diegel M; Neri F; Castillo A; Ibarrientos S; Lee K; Lescano N; Van Biber B; Nelson J; Halow J; Sandstrom R; Bates D; Urnov FD; Stamatoyannopoulos JA; Funnell APW
Cell Rep; 2020 May; 31(8):107676. PubMed ID: 32460018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
